HSP90AA1 and candidiasis: conducted a study in which they created a DNA vaccine expressing Hsp90 of C. albicans and a recombinant protein vaccine (r-hsp90-CA) to evaluate their effectiveness in combating candidiasis (Raska et al., 2005).